Cardiovascular Effects of Canagliflozin Vary According to Concomitant Metformin Use
The cardiovascular and renal effects of treatment with canagliflozin in patients with type 2 diabetes are more prominent in patients not taking metformin compared with patients treated with canagliflozin as an add-on to metformin.